EpiVario's Debt Round

EpiVario raised a round of funding on September 21, 2018.

EpiVario is a preclinical pharmaceutical company developing compounds to treat memory-related psychiatric disorders at the source of the disease.…

Articles about EpiVario's Debt Round: